Gasdermin D antagonizes immunosuppression in prostate cancer by inducing LAMC2 degradation to block M2 macrophage polarization
Qindan Du, Zhen Han, Yumeng Zhang, Ying Li, Ao Sun, Bin Wang, Yongquan Chen, Xiaoying Wang · 2026
Read Gasdermin D antagonizes immunosuppression in prostate cancer by inducing LAMC2 degradation to block M2 macrophage polarization by Qindan Du, Zhen Han, Yumeng Zhang, Ying Li, Ao Sun, Bin Wang, Yongquan Chen, Xiaoying Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218149.txt.
Description
Qindan Du and colleagues report a 2026 study uncovering a second, non-burning role for the protein gasdermin D in prostate cancer. The protein's front fragment is known to kill tumor cells by pyroptosis, a fiery form of cell death. What the full-length protein does in prostate cancer, particularly for immune evasion, was unexplored.
Using deletion models, the team found removing gasdermin D sped tumor growth, shortened survival, and created an immune-suppressed environment with fewer killer T cells. The protein binds a laminin subunit called LAMC2 and tags it for destruction. Without gasdermin D, LAMC2 accumulates and pushes macrophages into their M2 state. That state releases a chemokine, switching on growth signals and suppressing T cells. In human tumor samples, gasdermin D levels rose alongside T-cell infiltration and fell as suppressive macrophages rose. Activating the protein, the authors suggest, could thaw cold tumors and help immunotherapy.
Catalog record
| CREATOR | Qindan Du, Zhen Han, Yumeng Zhang, Ying Li, Ao Sun, Bin Wang, Yongquan Chen, Xiaoying Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |